1-20 of 200 results for subject:Pfizer
Librarians' tools
- Search time
- 0.225 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the terms of the indemnity against product liability given to Pfizer for the manufacture and supply of covid-19 vaccines are conditional upon the provision of accurate information on the results of trials of that vaccine undertaken prior...
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the terms of the indemnity against product liability given to Pfizer for the manufacture and supply of covid-19 vaccines are conditional upon the provision of accurate information on the results of trials of that vaccine undertaken prior...
We are not able to disclose the details of some clauses of contracts between the Government and vaccine manufacturers as this information is commercially sensitive.
To ask the Secretary of State for Business, Energy and Industrial Strategy, how much his Department has paid on average for each vaccine dose purchased from (a) AstraZeneca, (b) Moderna and (c) Pfizer BioNTech.
To ask the Secretary of State for Business, Energy and Industrial Strategy, how much his Department has paid on average for each vaccine dose purchased from (a) AstraZeneca, (b) Moderna and (c) Pfizer BioNTech.
We are not able to disclose specific costs of individual vaccines procured to date, as details of contracts between the Government and vaccine manufacturers are commercially sensitive.
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with relevant stakeholders on the availability of the Pfizer pill for covid-19 on the NHS.
To ask the Secretary of State for Health and Social Care, what recent discussions he has had with relevant stakeholders on the availability of the Pfizer pill for covid-19 on the NHS.
An updated interim clinical commissioning policy on the use of neutralising monoclonal antibody treatments and antivirals for non-hospitalised patients with COVID-19 was agreed by the United Kingdom Chief Medical Officers on 27 January 2022. This set out the intention to add PF-07321332+ritonavir (co-packaged as Paxlovid), manufactured by Pfizer, and remdesivir to the currently available treatment options for highest risk patients with COVID-19 from 10 February 2022.
NHS England has held webinars with stakeholders such as patient organisations, Royal Colleges, professional bodies and clinicians to support the introduction of the interim commissioning policy, with further engagement events and communications planned. Any decisions on deployment of community treatments, including Paxlovid, beyond the highest risk groups will be subject to the outcomes of the PANORAMIC study.
To ask the Secretary of State for International Trade, what steps the Government has taken in line with its support for voluntary licences to encourage (a) Pfizer and (b) Moderna to share their covid-19 vaccine technology with potential mRNA manufacturers across Africa, Latin America and Asia identified by MSF and...
To ask the Secretary of State for International Trade, what steps the Government has taken in line with its support for voluntary licences to encourage (a) Pfizer and (b) Moderna to share their covid-19 vaccine technology with potential mRNA manufacturers across Africa, Latin America and Asia identified by MSF and...
The role of the legal framework provided by the TRIPS Agreement has and will continue to provide innovators the confidence to invest in developing health products and technologies and to form collaborative partnerships. This is evidenced with over 300 successful voluntary licensing and technology transfer partnerships, which are contributing to the production of approximately 1.5 billion COVID-19 vaccine doses per month.
We encourage industry to continue forming voluntary licensing and technology transfer partnerships. Working with commercial partners within the existing international IP framework is the most effective way to make use of global capacity to produce life-saving medicines at pace.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the Government's contract for covid-19 vaccines with Pfizer includes an Investor State Dispute Settlement clause.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the Government's contract for covid-19 vaccines with Pfizer includes an Investor State Dispute Settlement clause.
The Department of Business, Energy and Industrial Strategy has advised that it is unable to disclose the details of some clauses of contracts between the Government and vaccine manufacturers as this information is commercially sensitive.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the Government's contract for covid-19 vaccines with Pfizer includes an investor state dispute settlement clause.
To ask the Secretary of State for Business, Energy and Industrial Strategy, whether the Government's contract for covid-19 vaccines with Pfizer includes an investor state dispute settlement clause.
We are not able to disclose the details of some clauses of contracts between the Government and vaccine manufacturers as this information is commercially sensitive.
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the Government has agreed to relating to the two contracts signed between Her Majesty’s Government (HMG) and...
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the Government has agreed to relating to the two contracts signed between Her Majesty’s Government (HMG) and...
My Rt Hon Friend the Secretary of State for Health and Social Care (Sajid Javid) has made the following written statement:
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention...
My Rt Hon Friend the Secretary of State for Health and Social Care (Sajid Javid) has made the following written statement:
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)
I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention...
To ask the Secretary of State for Business, Energy and Industrial Strategy, for what reason the Government agreed to (a) keep confidential and (b) hold outside of the UK any dispute with Pfizer on the contract that company holds for producing covid-19 vaccines; and if he will make a statement.
To ask the Secretary of State for Business, Energy and Industrial Strategy, for what reason the Government agreed to (a) keep confidential and (b) hold outside of the UK any dispute with Pfizer on the contract that company holds for producing covid-19 vaccines; and if he will make a statement.
The Government has agreed to keep confidential any dispute(s) that arise with Pfizer because of commercial sensitivity.
To ask the Secretary of State for International Trade, whether the Government's contract for covid-19 vaccines with Pfizer includes an Investor State Dispute Settlement clause.
To ask the Secretary of State for International Trade, whether the Government's contract for covid-19 vaccines with Pfizer includes an Investor State Dispute Settlement clause.
The Department for International Trade is not responsible for the United Kingdom’s COVID-19 vaccination programme.
To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the amount the NHS paid in 2021 for the Pfizer/BioNTech covid-19 vaccine; and what estimate he has made of the projected price for that Pfizer/BioNTech vaccine in (a) 2022 and (b) 2023.
To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the amount the NHS paid in 2021 for the Pfizer/BioNTech covid-19 vaccine; and what estimate he has made of the projected price for that Pfizer/BioNTech vaccine in (a) 2022 and (b) 2023.
We are not able to disclose specific costs of individual vaccines procured to date, as details of contracts between the Government and vaccine manufacturers are commercially sensitive.
To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 29 September 2021 to Question 52466 and the Answer of 13 September 2021 to Question 41806 on Coronavirus: Vaccination, for what reason he has not specified the date earlier this year that the...
To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 29 September 2021 to Question 52466 and the Answer of 13 September 2021 to Question 41806 on Coronavirus: Vaccination, for what reason he has not specified the date earlier this year that the...
Approximately 0.5 million Pfizer doses procured through COVAX were delivered on 30 June 2021. These doses helped the NHS deliver our vaccination programme as quickly as possible.
To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 13 September 2021 to Question 41806 on Coronavirus: Vaccination, on what date the approximately 0.5 million doses of the Pfizer vaccine the UK procured through COVAX were delivered.
To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 13 September 2021 to Question 41806 on Coronavirus: Vaccination, on what date the approximately 0.5 million doses of the Pfizer vaccine the UK procured through COVAX were delivered.
Approximately 0.5 million Pfizer doses procured through COVAX were delivered earlier this year. These doses helped the NHS deliver our vaccination programme as quickly as possible.
To ask the Secretary of State for Health and Social Care, whether a person who receives the first dose of the Pfizer covid-19 vaccine in England and the second dose in the United States will be regarded as fully vaccinated for the purpose of entry requirements in the UK.
To ask the Secretary of State for Health and Social Care, whether a person who receives the first dose of the Pfizer covid-19 vaccine in England and the second dose in the United States will be regarded as fully vaccinated for the purpose of entry requirements in the UK.
The Health Protection (Coronavirus, International Travel and Operator Liability) (England) Regulations 2021 states a traveller who has received one vaccine in England and another in the United States of America will not be regarded as fully vaccinated for the purpose of entry into the United Kingdom having passed through or transited through an amber country in the last 10 days.
Lords statement on Covid-19 vaccinations for 12 to 15-year-olds and the autumn and winter plan to manage the risk of Covid-19.
Lords statement on Covid-19 vaccinations for 12 to 15-year-olds and the autumn and winter plan to manage the risk of Covid-19.
Normally, of course, we would have taken these Statements separately but on this occasion, we can take them together. I hope we are working towards taking Statements on the day they are made in the Commons wherever possible.
I looked back at this week in 2020. This time last year, the...
Normally, of course, we would have taken these Statements separately but on this occasion, we can take them together. I hope we are working towards taking Statements on the day they are made in the Commons wherever possible.
I looked back at this week in 2020. This time last year, the...
My Lords, the publication of the 33-page Covid Autumn and Winter Plan, including plans A and B, rightly talks about the need to resume life as normally as is possible while Covid is still around, but to move into restrictions faster if cases surge and the NHS is pressured. The...
My Lords, the publication of the 33-page Covid Autumn and Winter Plan, including plans A and B, rightly talks about the need to resume life as normally as is possible while Covid is still around, but to move into restrictions faster if cases surge and the NHS is pressured. The...
I thank the noble Baronesses, Lady Thornton and Lady Brinton, for such thoughtful questions. I am very pleased to be here to answer questions on both these Statements, and I thank the noble Baroness, Lady Thornton, for her kind remarks earlier.
I too welcome the decision to bring forward the vaccination...
I thank the noble Baronesses, Lady Thornton and Lady Brinton, for such thoughtful questions. I am very pleased to be here to answer questions on both these Statements, and I thank the noble Baroness, Lady Thornton, for her kind remarks earlier.
I too welcome the decision to bring forward the vaccination...
My Lords, I join other noble Lords in congratulating the Government on the last two Statements and the decision to encourage vaccination in 12 to 16 year-olds. However, some teachers who have been very involved in assisting pupils with swabbing are concerned that there might be an expectation that they...
My Lords, I join other noble Lords in congratulating the Government on the last two Statements and the decision to encourage vaccination in 12 to 16 year-olds. However, some teachers who have been very involved in assisting pupils with swabbing are concerned that there might be an expectation that they...